Where AI Delivers Real ROI in Pharma Quality: Batch Review, Predictive Maintenance & Regulatory Drafting

What if your quality team could cut documentation errors by 70% and accelerate batch review cycles by 50% within a single year? That isn't hypothetical—it's a real outcome reported in 2024 by UST, where Merck redesigned its batch record processes using digital automation. The project showed a 70% reduction in documentation errors and a significant decrease in manual entries that historically slowed release.⁽¹⁾ More broadly, the latest McKinsey study estimates that 70% of processes in Pharma are agentifiable, with overall potential time savings of 30% across the Quality area.⁽²⁾

For Quality Directors and Regulatory Affairs leaders, the question has shifted. It's no longer whether AI can improve GMP processes—but which AI use cases deliver measurable ROI without compromising compliance under FDA 21 CFR Part 11, EU Annex 11, GMP, and GAMP 5. The answer starts with structured data, document automation, predictive quality analytics, and batch record transformation.

The Real Cost of Manual Quality Processes

You already know how tedious manual quality processes can be—but the scale of the problem is rarely quantified. Across global pharma operations, documentation remains one of the most persistent bottlenecks: manual batch record management and fragmented quality data lead to extended cycle times and repeated deviations, costing companies millions annually.

A 2024 analysis found that up to 25% of quality faults and 90% of product recalls in pharmaceutical manufacturing stem from human errors, including manual data entries.⁽³⁾ These errors compound when handwritten entries, scanned PDFs, and disconnected systems make SOPs hard to find or cross-reference.

We estimate that 60–80% of pharmaceutical operations still rely on paper batch records or scanned content, with some EBR processes also requiring manual checks against machine-specific reports or SOPs. A study from ArisGlobal found that most quality professionals consider regulatory workloads unsustainable, and 48% see AI as part of the solution—enabling them to transform routine regulatory work and considerably streamline processes.⁽⁴⁾

The fragmented landscape of document reviews doesn't just slow production—it limits your ability to extract meaningful insights. AI-assisted quality processes can only succeed when companies first convert unstructured quality documents into machine-readable, structured datasets. Without that foundation, predictive quality, automated deviation analysis, and risk modelling remain out of reach.

For global QA leaders under pressure to accelerate releases, reduce deviations, and maintain compliance, AI isn't optional—it's now a required tool to optimise operations and cope with increasing demands.⁽⁵⁾

Document Automation & Structured Data: The Foundation for the Strongest ROI

AI's highest-leverage impact begins with turning manual, unstructured quality documents into traceable, structured, compliant data.

Why this matters

Smart automation of manufacturing and quality processes depends heavily on converting human-generated content—batch records, stability reports, certificates of sterility, change control documents—into structured data that AI models can interpret and validate. Without this foundational step, automation simply cannot scale reliably.

What the data shows

McKinsey also finds that companies using advanced analytics are 23x more likely to outperform peers.

Use Case 1: Batch Review Automation Delivers High Cost & Time Savings

Few AI use cases deliver ROI as quickly as batch record automation—because batch release processes are repetitive, lengthy, and involve a lot of tedious yet necessary checks.

What the data shows

• Average batch review time is 4–8 hours when all data is correct
• Most paper batch reviews require 2–3 weeks total turnaround time⁽⁸⁾
• Digital review-by-exception processes deliver 90%+ total turnaround time improvements⁽⁹⁾
• Roche GenAI initiatives applied to deviation management accelerated investigations and reviews by 30–50%, as reported by Yiming Peng and Margaux Penwarden⁽¹⁰⁾

How AI helps

Structured document understanding and AI models can automatically:

• Check signatures, batch numbers, and dates
• Validate entries against specifications
• Flag missing or anomalous data
• Automatically draft the bill of materials
• Pre-populate QA deviation forms and review summaries
• Track sources of error over time to support improvement initiatives

How AI solutions support a GxP environment

Not all these benefits require GxP validation—many simply assist experts in saving time, while the expert retains control of final decisions and outputs. Solutions based on deterministic Machine Learning models, such as Acodis Batch Review, meet current requirements for validation in GxP environments.

It's not about review time alone—it's about total turnaround time. Saving 2 or 3 back-and-forth cycles between QA and operations alone can deliver significant ROI. In more advanced setups, the manufacturing team digitalises batch record documents and all subsequent changes are made digitally, with custom rules and alerts built per product.

Use Case 2: Predictive Quality & Maintenance Shifts QA From Reactive to Proactive

Once manufacturing and batch record data are structured, companies can enable predictive quality—a major ROI accelerator. Advanced applications typically use Machine Learning models rather than Generative AI, given the required specificity and trainable nature of the models.

Evidence from the research

Deloitte further estimates that predictive maintenance increases productivity by 25% and lowers maintenance costs by 25% on average.

Why predictive quality is high ROI

Predictive systems can detect early signals of process drift, avoid extended downtime from unforeseen failures, reduce batch failures and lost material, and prevent costly over-maintenance.

Case Example

Use Case 3: AI for Regulatory Document Generation Reduces Workload Across Quality & Regulatory Teams

Regulatory documentation and compliance tasks continue to consume increasing QA/RA resources—across dossier preparation, updates, and regulatory inspections. While the burden is most felt by regulatory teams, Quality teams must make their output readily consumable, auditable, and able to handle thousands of ad-hoc queries.

Where AI drives measurable value

Syngenta structured its medical leaflet and label database using Machine Learning and structured content solutions—enabled in part by Acodis technology (see case study)—for fast localisation and ongoing content control. Given that 20% of product recalls are linked to wrong labelling, the compliance value alone is substantial.

How Structured Authoring works⁽¹⁷⁾

• Template Design: A structured, dynamic blueprint that automatically includes or excludes content based on predefined conditions
• Document Instantiation: Populating the document with specific data and content
• Output Creation: Formatting and preparing the document for distribution
• Best-of-breed approach: Combining structured templates with GenAI content generation for both reliability and flexibility

Conclusion: Turning Quality Into a Strategic Accelerator

Quality teams have been cautious with AI deployment—and rightly so. But the increasing regulatory and process complexity of modern pharmaceutical manufacturing make digitalisation an absolute necessity for teams under pressure.

Between GxP-compliant Machine Learning tools like Acodis Batch Record Review and non-GxP generative AI use cases in predictive maintenance, Quality teams can leverage new technologies to streamline workflows, accelerate batch releases, reduce deviations, and cut costs.

In five years, AI and Machine Learning will be a prerequisite to staying competitive in Pharma Manufacturing and Quality. Those who move first—starting with targeted document automation and scaling to predictive and regulatory use cases—can begin today to release products faster, respond better to regulators, and turn quality from a bottleneck into a strategic accelerator of enterprise value.

The first step is a conversation. If you're ready to explore where AI can deliver the fastest ROI in your quality processes, our team can walk you through a free digitalisation audit based on your specific batch volumes, document types, and release cycle targets.